Enhancing the life-cycle of your insight

Elisa del Galdo|28th February 2020



The right kind of insight can help pharmaceutical and healthcare companies to be truly customer-centred and data-driven. It can provide a holistic understanding of customers and different aspects of their lives that likely affect their interaction with the business. For example, met and unmet needs, how they think and feel, what they value most, and what drives their decision-making process.

That’s why collecting the right data and extracting the right insight to inform your actions can show you how to best address real customer needs seamlessly.

Turning data into insight 

There is still some confusion around the difference between data and insight. At Blue Latitude Health, we define data as the raw and often unprocessed evidence, which normally takes the form of numbers and text. 

Insights are extracted through the process of data analysis. We interpret the data with the context and objective of its use in mind to draw conclusions and form meaningful, actionable ‘nuggets’ – insights.

The insight you extract from your data shouldn’t be ‘static’, or a single-use, onetime view of your customers, regardless of whether they are healthcare professionals, patients or caregivers. Your customers evolve; the landscape and context in which they operate changes, and so should your insight. In that regard, even the fact that your insights are changing (or not) is a valuable insight in itself. 

Falling into the negative insight lifecycle 

Generating insight is often expensive, which means it is essential to ensure the insights commissioned in one project can drive future strategies. However, in many cases, the ROI of the commissioned research is suboptimal. This is due to the negative insight lifecycle – a trap pharmaceutical and healthcare companies often fall into. This cycle results in insight being difficult to communicate, easily disregarded or stored somewhere on a server and forgotten. 

If our patients are diverse, why are clinical trials so white?

Ling Song|22nd June 2020

Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.

read more

How to run an engaging virtual workshop

Blue Latitude Health|15th June 2020

Our strategic consultants give their top tips for running an engaging virtual workshop. 

read more

Engaging physicians during COVID-19

Pany Koizi, Natasha Cowan|9th June 2020

COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.

read more